KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Gains from Investment Securities (2016 - 2025)

Pacific Biosciences Of California has reported Gains from Investment Securities over the past 16 years, most recently at -$232000.0 for Q4 2025.

  • For Q4 2025, Gains from Investment Securities fell 136.94% year-over-year to -$232000.0; the TTM value through Dec 2025 reached -$951000.0, down 168.17%, while the annual FY2025 figure was -$1.7 million, 368.79% down from the prior year.
  • Gains from Investment Securities for Q4 2025 was -$232000.0 at Pacific Biosciences Of California, up from -$719000.0 in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $12.3 million in Q1 2023 and troughed at -$5.4 million in Q2 2022.
  • A 5-year average of $2.8 million and a median of $899000.0 in 2024 define the central range for Gains from Investment Securities.
  • Biggest five-year swings in Gains from Investment Securities: plummeted 162.21% in 2022 and later soared 1252.96% in 2023.
  • Year by year, Gains from Investment Securities stood at $12.2 million in 2021, then plummeted by 75.83% to $2.9 million in 2022, then tumbled by 113.34% to -$392000.0 in 2023, then skyrocketed by 260.2% to $628000.0 in 2024, then tumbled by 136.94% to -$232000.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for PACB at -$232000.0 in Q4 2025, -$719000.0 in Q1 2025, and $628000.0 in Q4 2024.